Acute hepatocellular-cholestatic liver injury after olanzapine therapy [2]

Annals of Internal Medicine

Volumn 138, Issue 4, 2003, Pages 357-358

  Jadallah, Khaled A ^a   Limauro, David L ^a   Colatrella, Anthony M ^a  

^a MERCY HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OLANZAPINE;

ABDOMINAL PAIN; AGED; ANOREXIA; ARTHRALGIA; CASE REPORT; DEPRESSION; DRUG TOLERABILITY; FEMALE; FEVER; HUMAN; INTRAHEPATIC CHOLESTASIS; LETTER; LIVER TOXICITY; MALAISE; NAUSEA; PRIORITY JOURNAL; PSYCHOSIS;

EID: 0037452527     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-138-4-200302180-00024     Document Type: Letter

References (9)

1. Beasley CM Jr, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial. Neuropsychopharmacology. 1996;14:111-23. [PMID: 8822534]
2. Beasley CM Jr, Sanger T, Satterlee W, Tollefson G, Tran P, Hamilton S. Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial. Psychopharmacology (Berl). 1996;124:159-67. [PMID: 8935812]
3. Kellner M, Wiedemann K, Krieg JC, Berg PA. Toxic hepatitis by clozapine treatment [Letter]. Am J Psychiatry. 1993;150:985-6. [PMID: 8494085]
4. Krebs S, Dormann H, Muth-Selbach U, Hahn EG, Brune K, Schneider HT. Risperidone-induced cholestatic hepatitis. Eur J Gastroenterol Hepatol. 2001;13:67-9. [PMID: 11204814]
5. Maria VA, Victotino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology. 1997;26:664-9. [PMID: 9303497]
6. Gerber JE, Cawthon B. Overdose and death with olanzapine: two case reports. Am J Forensic Med Pathol. 2000;21:249-51. [PMID: 10990286]
7. Zyprexa [package insert]. Indianapolis, IN: Eli Lilly; 1997.
8. Gómez JC, Sacristán JA, Hernández J, Breier A, Ruiz Carrasco P, Antón Saiz C, et al. The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic Study of Olanzapine in Schizophrenia. J Clin Psychiatry. 2000;61: 335-43. [PMID: 10847307]
9. Tollefson GD, Beasley CM Jr, Tran PV, Street JS, Krueger JA, Tamura RN, et al. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry. 1997;154:457-65. [PMID: 9090331]